Diagnostics Industry
Filter News
Found 1,908 articles
-
Fujifilm Offers Educational Initiatives and Showcases Full Suite of Diagnostic Imaging and Healthcare IT Solutions at RSNA 2018
11/15/2018
Company sponsors two symposiums; awards research grants; exhibits comprehensive imaging and healthcare IT portfolio
-
Luxia Scientific launches its European gut microbiome test in Luxembourg
11/15/2018
Luxia Scientific, a French biotech dedicated to improving wellbeing and health for all through the analysis and understanding of the microbiome, announces the availability of its test “1test1TM” in Luxembourg. The test was launched in France beginning of October 2018.
-
Agilent Completes Acquisition of ACEA Biosciences
11/14/2018
Acquisition Brings Together Two Pioneers in Cellular Function and Metabolism Measurements
-
VIDA Previews LungPrint™, An AI-Powered Lung Imaging Analytics Solution Launching At RSNA 2018
11/14/2018
VIDA Diagnostics ("VIDA"), the leader in pulmonary imaging analytics, announced it will launch LungPrint™ Discovery, an innovative AI-powered lung analysis solution for radiologists, at the Radiological Society of North America's (RSNA) 104th Scientific Assembly and Annual Meeting, November 25-30 in Chicago.
-
Trace Genomics Raises $13m Series A Round to Unlock the Power of the Soil for Farmers
11/13/2018
Trace Genomics® AI-enabled diagnostic tools for farmers to increase yields and reduce costs, has closed a $13 million Series A round.
-
GeneNews Announces Third Quarter 2018 Results Investor Call
11/13/2018
Conference Call – 8:30am Thursday, November 15th
-
Biocept Reports Third Quarter 2018 Financial Results
11/13/2018
Company to host conference call at 4:30 p.m. Eastern time today
-
Study Demonstrating Accuracy of DecisionDx-Melanoma Prognostic Test Across Melanoma Tissue Sources Presented at the American Society of Dermatopathology 55th Annual Meeting
11/13/2018
Castle Biosciences, Inc. today announced study results showing that the DecisionDx-Melanoma test accurately predicts risk for patients with cutaneous melanoma when using either biopsy or wide local excision (WLE) as the tissue source.
-
FTC Seeks Expert Advice from IDx CEO on Safely Introducing Real-World AI
11/13/2018
Dr. Michael Abramoff invited to participate in a Federal Trade Commission hearing on ethical and consumer protection issues related to real-world AI applications
-
Expanding Applications of NX Prenatal's Exosome-Based Diagnostics Platform Presented at Key Conferences
11/13/2018
NX Prenatal Inc. announced today that expanding applications of its proprietary NeXosome® liquid biopsy platform were presented at recent scientific conferences.
-
New Diagnostic Test Helps Hospitals More Quickly Identify and Treat Emerging Antibiotic-Resistant Bacteria
11/13/2018
Fully-automated BD Phoenix™ CPO Detect Test Receives U.S. FDA Clearance.
-
The Baltimore Longitudinal Study of Aging was launched in 1958 by the National Institutes of Health. The idea was to follow and study the lives of healthy, active people over their lifetimes, rather than after they were dead.
-
Quidel to Present at the 30th Annual Piper Jaffray Healthcare Conference
11/12/2018
Quidel Corporation announced today that it will present at the 30th Annual Piper Jaffray Healthcare Conference, to be held at the Lotte New York Palace hotel in New York, New York on Wednesday, November 28, 2018.
-
Hundreds of millions of dollars have been pledged by billionaires to advance scientific research.
-
Saliva-Based RNA Panel Accurately Distinguishes Children with Autism Spectrum Disorder from Non-Autistic Peers, Including Children with Developmental Delays
11/9/2018
Results from multi-institutional research collaboration published in Frontiers in Genetics journal
-
Quest Diagnostics to Showcase New Data at the American Heart Association 2018 Scientific Sessions
11/9/2018
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that it will present results of three studies at the 2018 American Heart Association Scientific Sessions in Chicago.
-
Exact Sciences to participate in two November 208 investor conferences
11/9/2018
Exact Sciences Corp. today announced that company management will be presenting at the following investor conference during November and invited investors to participate by webcast.
-
Natera Reports Third Quarter 2018 Financial Results
11/8/2018
Natera, Inc. today reported financial results for the third quarter ended September 30, 2018, and provided an update on recent business progress.
-
Veracyte Announces Publication of Data Demonstrating “Real World” Performance of Afirma GSC in Thyroid Cancer Diagnosis
11/8/2018
Veracyte, Inc. announced today the publication of “real world” data showing that the Afirma® Genomic Sequencing Classifier (GSC) enables even more patients to avoid unnecessary surgery in thyroid cancer diagnosis compared to the company’s flagship, original Afirma Gene Expression Classifier (GEC). The findings are published online in Endocrine Practice, the journal of the American Association of Clinical Endocrinologists.
-
CENTOGENE Earns Accreditation to ISO 15189:2012 from CAP
11/8/2018
The College of American Pathologists has awarded CENTOGENE AG accreditation to the ISO15189 standard under the CAP 15189SM Accreditation Program.